Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience
- PMID: 33968454
- PMCID: PMC8081640
- DOI: 10.1155/2021/6654229
Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience
Abstract
Primary liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma, are a major cause of cancer-related morbidity and mortality worldwide. There are several histologically and biologically distinct subtypes of liver cancer that have previously been reported. However, literature regarding the nonsurgical management of these patients upon disease recurrence remains limited. These variants include combined HCC-cholangiocarcinoma (cHCC-CC), Epstein-Barr virus- (EBV-) associated carcinoma, undifferentiated carcinoma, and clear cell or thyroid-like variants of HCC. Here, we aim to highlight the pathologic features, clinical course, and outcomes of five patients with these unusual hepatic tumors and explain the rationale behind the choice of their systemic therapies upon disease recurrence. All patients underwent surgical resection as the standard of care for localized disease, and upon relapse, they were treated with either chemotherapy, targeted therapy, immunotherapy, or active surveillance based on the clinical context and tumor histology. These rare variants are important to recognize as they have prognostic and therapeutic implications, and there are currently insufficient data in the literature to guide further therapy.
Copyright © 2021 Brandon Swed et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures





Similar articles
-
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27. Ann Surg Oncol. 2012. PMID: 22451237
-
A Patient's Journey With Rare Biphenotypic Hepatocellular Carcinoma and Cholangiocarcinoma.Cureus. 2020 Aug 18;12(8):e9838. doi: 10.7759/cureus.9838. Cureus. 2020. PMID: 32953345 Free PMC article.
-
Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.Liver Transpl. 2014 Aug;20(8):952-9. doi: 10.1002/lt.23897. Epub 2014 Jul 3. Liver Transpl. 2014. PMID: 24777610
-
Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity.Ann Hepatol. 2014 May-Jun;13(3):317-22. Ann Hepatol. 2014. PMID: 24756005 Review.
-
Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma.Chin Clin Oncol. 2016 Oct;5(5):66. doi: 10.21037/cco.2016.10.02. Chin Clin Oncol. 2016. PMID: 27829279 Review.
Cited by
-
Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma: A report of 3 cases and literature review.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Feb 28;49(2):319-330. doi: 10.11817/j.issn.1672-7347.2024.230298. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38755729 Free PMC article. Review.
-
Case report: Rare observation of thyroid-like cholangiocarcinoma.Front Med (Lausanne). 2025 Jan 23;11:1458586. doi: 10.3389/fmed.2024.1458586. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39917266 Free PMC article.
-
Clinicopathological Study on Morphological Subtypes of Hepatocellular Carcinoma: A Single Tertiary Referral Center Experience.Cancer Rep (Hoboken). 2025 Feb;8(2):e70127. doi: 10.1002/cnr2.70127. Cancer Rep (Hoboken). 2025. PMID: 39953652 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures 2020. Atlanta, GA, USA: American Cancer Society; 2020.
-
- Zimmerman A. Tumors and Tumor-like Lesions of the Hepatobiliary Tract: General and Surgical Pathology, 1st. Geneva, Switzerland: Springer International Publishing; 2017. pp. 151–156.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources